GERD in Children With Cystic Fibrosis

Recruiting now · Not applicable

Conditions studied: GERD in Children, Cystic Fibrosis in Children

In brief

The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.

Key facts

Study ID

NCT06617013

Run by

Duke University

People needed

20

Starts

2024-10-23

Expected to finish

2026-06-30

Last updated by the study team

2025-12-19

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children 2-18 years of age with a confirmed CF diagnosis by either a positive sweat test or 2 disease causing CFTR mutations.
• Signed consent

You may not qualify if…

• Declining to participate in the study or sign consent
• History of severe GERD per gastroenterology diagnosis and documentation
• GSAS score >80

Where it is running

• Duke University Hospital — Durham, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.